BS and MoreiraRA. Compositional and nutritional
attributes of seedsfrom the multipurpose tree
Obayuwana et al; Histological Effects of Aqueous Extract of Moringa oleifera on the Liver Tissues of Wistar rats fed with High Fat Diet Moringa oleifera Lamarck. J SciFood Agric.
1999;79:815–820.
2. D’souza J and Kulkarni AR. Comparative studies on
nutritivevalues of tender foliage of seedlings and mature plants ofMoringa oleifera Lam. J Econ Taxon Bot.1993;17: 479-485.
3. Anwar F, Ashraf MandBhanger MI. Interprovenance variationin the composition of Moringa oleifera oilseeds fromPakistan. J Am Oil Chem Soc.2005;82:45-51.
4. Agarwal B and MehtaA. Antiasthmatic activity of Moringa oleifera lam: A clinical study. Indian Journal of pharmacology.2008;40(1):28-31.
5. Caceres A, Cabrera O, Morales O, Mollinedo P andMendia P.Pharmacological properties of Moringa oleifera. 1: Preliminaryscreening for antimicrobial activity. J Ethnopharmacol.1991;33:213-216.
6. Caceres A, SaraviaA, Rizzo S, Zabala L, Leon ED and Nave F. Pharmacologic properties of Moringa oleifera: 2: Screening forantispasmodic, anti- inflammatory and diuretic activity. J Ethnopharmacol.1992;36:233-237.
7. Dangi SY, Jolly CIandNarayana S. Antihypertensive activityof the total alkaloids from the leaves of Moringa oleifera.Pharm Biol.2002;40:144-148.
8. .Guevara AP, Vargas C, and Sakurai H. An antitumorpromoter from Moringa oleifera Lam Mutat Res.1999;440: 181-188.29.
9. HukkeriVI, NagathanCV, KaradiRV andPatilSV.Antipyretic and wound healing activities of moringa oleifera lam in rats. Indian J. Pharm. Sci. 2006;68 (1):124-126.
10. ShuklaS, Matur R and PrakashAO. Antifertility profile of the aqueous extract of Moringa oleifera roots. J. Ethanopharmacol.1988;22(1):51-62.
11. Gilani AH, Aftab K and Shaheen F. Antispasmodic activityof active principle from Moringa oleifera. In Natural Drugsand the Digestive Tract, Capasso F,
12. .Gilani AH, Aftab K and Suria A.Pharmacological studieson hypotensive and spasmodic activities of pure compoundsfrom Moringa oleifera. Phytother Res. 1994a;8: 87-9 Mormodical chanratia in Isoproterenol –Induced 29. Gudbrandsen OA, Rost TH, and Berge RK. Causes Myocardial Infarction in Adult Rats. Arch. Bas.App. and prevention of tamoxifen-induced accumulation
of triacylglycerol in rat liver. J Lipid Res.
2006;47(10):2223-32.
30. Patel AA, Torres DM,and Harrison SA. Effect of
weight loss on non-alcoholic fatty liver disease. J
Clin Gastroenterol. 2009;43:970–4.
31. Musso G, Gambino R, and Cassader M. Non-
alcoholic fatty liver disease from pathogenesis to management: An update. Obes Rev. 2010;11:430– 45.
32. Haukeland JW, Konopski Z, Eggesbø HB, von Volkmann HL, Raschpichler G,and Bjøro K, Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial. Scand J Gastroenterol. 2009;44:853–60.
33. Capanni M, and Calella F, . Prolonged omega- 3polyunsaturated fatty acid supplementation ameliorates hepatic steatosisin patients with non- alcoholic fatty liver disease. Aliment Pharmacol Ther,2006;23:1143-51.
34. Chou SC,and Chen KW, . The add-on effects of Gynostemmapentaphyllum on nonalcoholic fatty liver disease. Altern Ther HealthMed, 2006; 12:34- 9.
35. Park SH, Lee SG, Kang SK,and Chung SH. Acanthopanaxsenticosus reverses fatty liver disease and hyperglycemia in ob/ob mice.Arch Pharm Res, 2006; 29:768-776.
36. Zhou GD, Li MR, Zhang J, Pan D , Zhao SX, Yang JF, Yu J,and Zhao JM. Chitosan ameliorates the severity of steatohepatitis induced byhigh fat diet in rats. Scand J Gastroenterol, 2008; 43: 1317-7.
37. Takayama F, Nakamoto K, Kawasaki H, and Mankura M .Beneficial effects of Vitis coignetiae pulliat leaves on nonalcoholicsteatohepatitis in a rat model. Acta Med Okayama, 2009; 63:105111.
38. Zheng S, Hoos L, Cook J, Tetzioff G, Davis H, Van Heek M,Hwa J. and Ezetimibe. improves high fat and cholesterol diet-induced nonalcoholicfatty liver disease in mice. Eur J Pharmacol, 2008; 584:118- 124.
Obayuwana et al; Histological Effects of Aqueous Extract of Moringa oleifera on the Liver Tissues of Wistar rats fed with High Fat Diet
Med.4,(2016)19-40.
20. Sharma N, Garg V and Paul A.
Antihyperglycemic,antihyperlipidemic and antioxidative potential of Prosopis cineraria bark.Ind J Clin Biochem, 2010; 25:193-200.
21. Drury, R, A. B. and Wallington, E. A. Carleton`s histological techniaue 5th ed. Oxford, New York, Toronto: Oxford University Press,1980. 139-142, 248-249.
22. Burt AD, Mutton A,and Day CP. Diagnosis and interpretation ofsteatosis and steatohepatitis. Semin Diagn Pathol, 1998; 15:246-58.
23. Marques CM, Motta VF, Torres TS, Aquila M, and Mandarim CA.Beneficial effects of exercise training on insulin resistance andnonalcoholic fatty liver disease in high-fat fed C57BL/6 mice. Braz J MedBiol Res, 2010; 43:467-75.
24. Buettner R, Parhofer KG, Woenckhaus M, Wrede CE, Kunz-Schughart LA, Schölmerich J, and Bollheimer LC. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol. 2006;36:485–501.
25. Wang W, Zhao C, Zhou J, Zhen Z, Wang Y, Shen C.and Simvastatin. ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non- alcoholic steatohepatitis-related liver fibrosis. PLoS One. 2013;8:e76538.
26. Xu ZJ, Fan JG, Ding XD, Qiao L,and Wang GL. Characterization of high-fat, diet-induced, non- alcoholic steatohepatitis with fibrosis in rats. Dig Dis Sci. 2010;55:931–940.
27. Zhang W, Wang LW, Wang LK, Li X, Zhang H, Luo LP, Song JC,and v Gong ZJ. Betaine protects against high-fat-diet-induced liver injury by inhibition of high-mobility group box 1 and Toll-like receptor 4 expression in rats. Dig Dis Sci. 2013;58:3198–3206.
28. Cole LK, Jacobs RL,and Vance DE. Tamoxifen induces triacylglycerol accumulation in the mouse liver by activation of fatty acid synthesis. Hepatology. 2010;52(4):1258-65.
- Abstract viewed - 944 times
- PDF downloaded - 806 times
Copyright
© ,
Affiliations
Obayuwana E
Department of Anatomy, School of Basic Medical sciences, College of Medical sciences, University of Benin, Benin City, Nigeria.
Ubhenin A. E
Department of Biochemistry, Faculty of Basic Health science, Federal University Lafia, Nasarawa, Nigeria.
Innih S. O
Department of Anatomy, School of Basic Medical sciences, College of Medical sciences, University of Benin, Benin City, Nigeria
Iwee R
Department of Anatomy, School of Basic Medical sciences, College of Medical sciences, University of Benin, Benin City, Nigeria.
Eidaghese E.C
Department of Anatomy, School of Basic Medical sciences, College of Medical sciences, University of Benin, Benin City, Nigeria
How to Cite
Most read articles by the same author(s)
- Ubhenin A. E, Innih S. O, Okobi S.C, Lawal E.T, Obayuwana E, Hypolipidemic Effect of Ethanolic Extract of Cyperus esculentumis in TritonWR-1339-Induced Hyperlipidemic Rats , International Journal of Forensic Medical Investigation: Vol 2 No 2 (2016): Volume 2, Number 2
Hypolipidemic Effect of Ethanolic Extract of Cyperus esculentumis in TritonWR-1339-Induced Hyperlipidemic Rats
Vol 2 No 2 (2016): Volume 2, Number 2
Submitted: Jul 4, 2019
Published: Apr 2, 2018
Abstract
Currently, there has been an observed interest in phytochemicals as a new hypolipidemic agents to replace synthetic toxic hypolipidemic drugs. The investigation was carried out to evaluate the hypolipidemic effects of ethanolicextract of Cyperus esculentumis in triton-induced hyperlipidemic rats. The ethanolic extract of the plant was administered orally to rats at the doses of 300,400 and 600mg/kg body weight for a period of twenty nine days in accordance with the Ethical committee on experimental animals. Hyperlipidemia was developed by interaperitoneal injection of Triton at a dose 250mg/kg b.wt. to wistar rats. Intraperitoneal injection of Triton WR-1339 at a dose of 250mg/kg to rats resulted in the increase in serum triglyceride, total cholesterol , low density and very low density lipoproteins cholesterol accompanied by reduction in the high density lipoprotein cholesterol .The histopathological examination also revealed that there were remarkable histopathological changes in the aorta and artery of rats induced with Triton WR-1339 . The damages were manifested as ulceration and stenosis .Pretreatment with the ethanolic tuber extract of Cyperus esculentumis led to significant reduction of TC, TG, LDL and VLDL cholesterol in triton-induced hyperlipidemic rats as compared to the control. There was also an increased in HDL-cholesterol and attenuation of histopathological damages. Among the different doses administered, only 600 mg/kg exhited statistical significant effects. Other doses 300 and 400mg/kg showed mild toxicity. This finding suggests that the cholesterol-lowering effect of Cyperus esculentumis may be due to the enhancement of LDL-C metabolism which might be attributed to the presence of the valuable phytochemicals in the extract.
Keywords: Cyperus esculentumis, Hyperlipidemia, phytochemicals, ulceration, stenosis.